|
EU manufacturers call for urgent reforms to achieve reciprocity and a level-playing field in public procurement |
Medicines for Europe |
30 Sep 2019 |
Health & Consumers |
|
Immediately calls on new President of EU Commission to prioritise Healthcare |
Medicines for Europe |
25 Sep 2019 |
Health & Consumers, InfoSociety |
|
A DIGITAL FUTURE FOR VALUE ADDED MEDICINES – IQVIA publication shares the future of the sector |
Medicines for Europe |
24 Sep 2019 |
Health & Consumers |
|
Ready to drive access to medicines |
Medicines for Europe |
24 Jul 2019 |
Health & Consumers |
|
‘Together for Health’: Medicines for Europe launches election manifesto to deliver on equitable patient access |
Medicines for Europe |
03 Apr 2019 |
Health & Consumers |
|
New safeguards for patient safety as Falsified Medicines Directive comes into force |
Medicines for Europe |
11 Feb 2019 |
Health & Consumers |
|
SPC manufacturing waiver cannot be derailed by foreign vested interests |
Medicines for Europe |
07 Feb 2019 |
Health & Consumers |
|
Efficient use of pharmacovigilance data essential for patient safety |
Medicines for Europe |
30 Jan 2019 |
Health & Consumers |
|
Competition policy essential for access to medicines |
Medicines for Europe |
29 Jan 2019 |
Health & Consumers |
|
Crucial European Parliament vote vastly improves SPC manufacturing waiver |
Medicines for Europe |
24 Jan 2019 |
Health & Consumers |
|
Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver! |
Medicines for Europe |
04 Dec 2018 |
Health & Consumers |
|
Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines. |
Medicines for Europe |
30 Nov 2018 |
Health & Consumers |
|
Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI). |
Medicines for Europe |
28 Nov 2018 |
Health & Consumers |
|
Health at a Glance Report highlights public value of generic, biosimilar and value added medicines |
Medicines for Europe |
26 Nov 2018 |
Health & Consumers |
|
Value added medicines: Continuous innovation crucial to improve healthcare across Europe |
Medicines for Europe |
21 Nov 2018 |
Health & Consumers |
|
Driving local excellence, delivering European results |
Medicines for Europe |
06 Nov 2018 |
Health & Consumers |
|
US interference unacceptable in EU legislative proposal for an SPC manufacturing waiver |
Medicines for Europe |
22 Oct 2018 |
Health & Consumers |
|
Risk that European Council will “neuter” SPC manufacturing waiver and give foreign (non-EU) manufacturers strong advantage over EU-based manufacturers |
Medicines for Europe |
12 Oct 2018 |
Health & Consumers |
|
CJEU decision on Gilead’s SPC on Truvada® leads to successful clarification in English court |
Medicines for Europe |
20 Sep 2018 |
Health & Consumers |
|
SPC manufacturing waiver moves a step closer as influential European Parliament ENVI Committee supports reform |
Medicines for Europe |
18 Sep 2018 |
Health & Consumers |
|
European Organisation for Specialised Nurses (ESNO) launches switch management guide between similar biological medicines - a guide for nurses |
Medicines for Europe |
26 Jun 2018 |
Health & Consumers |
|
Medicines for Europe members publish disclosure of Transfers of Value to the healthcare community |
Medicines for Europe |
22 Jun 2018 |
Health & Consumers |
|
Access, sustainability and manufacturing competitiveness highlighted at global generic, biosimilar and value added pharmaceutical conference in Budapest |
Medicines for Europe |
14 Jun 2018 |
Health & Consumers |
|
Comprehensive SPC manufacturing waiver key for patient access to medicines, jobs and growth in Europe |
Medicines for Europe |
28 May 2018 |
Health & Consumers, Social Europe & Jobs |
|
EU Semester Country Specific Recommendations: Improve patient access to medicine and ensure healthcare sustainability |
Medicines for Europe |
24 May 2018 |
Health & Consumers |
|
Biosimilar Medicines: essential for sustainable access to medicines |
Medicines for Europe |
27 Apr 2018 |
Health & Consumers |
|
SPC manufacturing waiver, Competition policy, Brexit, pharma incentives European Patent Office take centre stage at 14th Legal Affairs Conference |
Medicines for Europe |
25 Apr 2018 |
Health & Consumers |
|
Supply chain commitment to tackling problem of medicine shortages |
Medicines for Europe |
02 Mar 2018 |
Health & Consumers |
|
IGBA launches a Biosimilar Medicines Information Campaign |
Medicines for Europe |
01 Feb 2018 |
Health & Consumers |
|
IGBA congratulates the Australian Government for maintaining their Biologics Naming Convention and for strengthening pharmacovigilance |
Medicines for Europe |
29 Jan 2018 |
Health & Consumers |
